NCT00953680View on ClinicalTrials.gov

Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2004

Study Completion Date

July 31, 2004

Conditions
Hypertension
Interventions
DRUG

losartan potassium (+) hydrochlorothiazide (HCTZ)

Single dose losartan 100 mg/HCTZ 12.5 mg combination tablet in one of two treatment periods.

DRUG

losartan potassium

Single dose losartan 100 mg tablet in one of two treatment periods.

DRUG

hydrochlorothiazide (HCTZ)

Single dose HCTZ 12.5 mg capsule in one of two treatment periods.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00953680 - Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306) | Biotech Hunter | Biotech Hunter